Its anti-tumor actions include halting cell proliferation by upregulating p21/WAF-1, enhancing p53 expression, and inhibiting BAFF and MMP9, alongside activating FcgR and recognizing tumor cell oligosaccharides through natural antibodies in the plasma (11, 13, 14, 17–19). This evidence concerns the gene CDKN1A and neoplasm.